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Abstract
Background: Drug and contrast agent delivery systems that achieve controlled release in the presence of
enzymatic activity are becoming increasingly important, as enzymatic activity is a hallmark of a wide array of
diseases, including cancer and atherosclerosis. Here, we have synthesized clusters of ultrasmall superparamagnetic
iron oxides (USPIOs) that sense enzymatic activity for applications in magnetic resonance imaging (MRI). To achieve
this goal, we utilize amphiphilic poly(propylene sulfide)-bl-poly(ethylene glycol) (PPS-b-PEG) copolymers, which are
known to have excellent properties for smart delivery of drug and siRNA.
Results: Monodisperse PPS polymers were synthesized by anionic ring opening polymerization of propylene
sulfide, and were sequentially reacted with commercially available heterobifunctional PEG reagents and then ssDNA
sequences to fashion biofunctional PPS-bl-PEG copolymers. They were then combined with hydrophobic 12 nm
USPIO cores in the thin-film hydration method to produce ssDNA-displaying USPIO micelles. Micelle populations
displaying complementary ssDNA sequences were mixed to induce crosslinking of the USPIO micelles. By design,
these crosslinking sequences contained an EcoRV cleavage site. Treatment of the clusters with EcoRV results in a
loss of R2 negative contrast in the system. Further, the USPIO clusters demonstrate temperature sensitivity as
evidenced by their reversible dispersion at ~75°C and re-clustering following return to room temperature.
Conclusions: This work demonstrates proof of concept of an enzymatically-actuatable and thermoresponsive
system for dynamic biosensing applications. The platform exhibits controlled release of nanoparticles leading to
changes in magnetic relaxation, enabling detection of enzymatic activity. Further, the presented functionalization
scheme extends the scope of potential applications for PPS-b-PEG. Combined with previous findings using this
polymer platform that demonstrate controlled drug release in oxidative environments, smart theranostic
applications combining drug delivery with imaging of platform localization are within reach. The modular design
of these USPIO nanoclusters enables future development of platforms for imaging and drug delivery targeted
towards proteolytic activity in tumors and in advanced atherosclerotic plaques.
Background
Enzymatic activity is understood to be a hallmark of var-
ious diseases, including cancer and atherosclerosis [1,2].
Consequently, enzymatically-sensitive drug- and contrast
agent-delivery platforms are of great interest in medical
areas. Enzymatically-sensitive controlled release plat-
forms have been previously investigated for drug
delivery [3-5]. While they have also been investigated
for molecular imaging, most of these efforts have been
concentrated in the areas of optical imaging and nuclear
imaging [1,6,7]. In many cases, these techniques are dis-
advantageous for in vivo applications because optical
imaging is significantly limited by tissue autofluores-
cence and light absorbance, while nuclear imaging can
expose the patient to relatively high doses of ionizing
radiation. Magnetic resonance imaging (MRI) is not lim-
ited by these issues and provides the advantages of high
spatial resolution and excellent soft tissue contrast. Only
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a few examples of enzymatically-sensitive platforms for
MRI applications have been previously reported, as
reviewed elsewhere [1].
Ultrasmall superparamagnetic iron oxides (USPIOs)
have been widely investigated for applications as MRI
contrast agents and for probing intermolecular interac-
tions due to their strong T2 magnetic relaxation proper-
ties [8-11]. As contrast agents, USPIOs have unique
characteristics, including high detection sensitivity, rela-
tively low toxicity, and the potential for long circulation
half-lives [12,13]. To produce USPIOs of uniform com-
position, size, and physical properties, thermal decom-
position synthesis is preferred, but the process yields
USPIO cores coated with a layer of the hydrophobic
surfactant oleic acid [14].
Especially for our applications, biocompatible, bioac-
tive USPIO-based contrast agents must exhibit solubility
and stability in water and, in many cases, to display
ligands such as whole proteins, peptides, or nucleic
acids. In order to achieve this goal, a modular approach
for functionalizing USPIOs is generally followed. Various
methods for rendering USPIOs water-soluble are well-
documented, including covalent methods such as silani-
zation or the formation of micelles with polymers or
phospholipids [8,15-18]. A wide range of techniques in
bioconjugate chemistry can then be used to immobilize
bioactive ligands onto the USPIO surface [19].
Some USPIO formulations are biocompatible and have
been clinically approved for human use, such as Feridex
and GastroMARK [20-22]. However, nanoparticle bio-
compatibility is largely determined by surface properties,
independent of USPIO characteristics. Because of this,
in vivo biodistribution must be determined for each
unique formulation [23-26].
In recent years, the encapsulation of USPIOs in micel-
lar structures by self-assembly with amphiphilic PEG-
containing block copolymers has received attention
[17,27,28]. Recently, extensive studies by the Hubbell
group have shown that amphiphilic block copolymers of
PEG and the hydrophobic poly(propylene sulfide) (PPS)
can be used to generate micellar and multilamellar
structures for drug delivery applications [29,30]. These
copolymers have received interest for their unique char-
acteristics, including a PPS block capable of undergoing
a hydrophobic-to-hydrophilic transition in oxidative
environments, resulting in environmentally-sensitive
drug release [30,31]. Though previously uninvestigated
as a USPIO coating, the PEG-PPS copolymers display
material properties that presumably enable the construc-
tion of novel oxidation-responsive “theranostic” (thera-
peutic-diagnostic) agents in the near future. To add to
these properties, PEG-PPS copolymers have been suc-
cessfully tagged with bioactive ligands such as peptides
for actively targeted drug delivery [32]. Here, we report
the broader utility of the PEG-PPS copolymer platform
through the synthesis of PPS-PEG-ssDNA constructs,
and the self-assembly of these constructs onto highly
monodisperse USPIO cores to generate multifunctional
magnetofluorescent nanoparticles.
To demonstrate the applicability of the approach,
these novel ssDNA-tagged USPIOs will then be assessed
as magnetic relaxation switches (MRS) [33]. The MRS
concept indicates that clustering of USPIOs leads to a
significant increase in R2 relaxivity of the USPIOs, while
redispersion of the USPIOs returns R2 to baseline levels.
The MRS label originated from the behavior of the sys-
tem as a nanosensor capable of being turned on or off
in the presence of a specific environmental stimulus,
which, in this study, is restriction enzyme activity. Com-
plementary populations of ssDNA-USPIOs were mixed
to form self-assembled clusters. These clusters were
subjected to restriction enzyme treatment or thermocy-
cling to exert controlled release of the USPIO cores.
Light scattering and relaxation measurements were car-
ried out on clustered and declustered MRS in aqueous
solution. The work presented here offers a flexible plat-
form for generating biocompatible, MR-visible nanoma-
terials with T2 relaxivities modulated by enzyme activity
that presumably enable in vivo biosensing by modula-
tion of image contrast.
Results and Discussion
Synthesis of PEG-PPS block copolymers and
encapsulation of USPIO cores
The anionic ring opening polymerization scheme allows
some degree of flexibility in fashioning PPS blocks with
various functional groups on both ends of the polymer
chain. This is done by varying the initiator and the
chain terminator used in the reaction [34-38]. Etha-
nethiol was chosen as an initiator because the thiol is
easily deprotonated by a small excess of DBU, without
significant risk of the DBU leading to side products dur-
ing the polymerization process (Figure 1). Injection of a
stoichiometric amount of the propylene sulfide mono-
mer forms the PPS block, and the reaction is endcapped
with methyl acrylate via a Michael-type addition
mechanism [35]. Hydrolysis of the terminal methyl ester
under alkaline conditions fashioned PPS-COOH, at
1.65 kDa and PDI 1.18 (Table 1, Figure 2a). Acrylic acid
was also investigated as an endcapping agent for the liv-
ing polymerization in an attempt to fashion PPS-COOH
in a single step, but resulted in undesirable side pro-
ducts that were likely formed by competing mechanisms
to Michael-type addition (data not shown). Attachment
of the PEG block and the ssDNA block were both done
via well-characterized carbodiimide chemistry [19].
The construction of carboxylated PEG-PPS (cPEG-PPS)
was confirmed via FT-IR (Figure 2b) and NMR
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spectroscopies, and further visualized by GPC, as the
copolymers exhibited an elution peak centered at
around 9 min that was not seen on the elution profiles
of either of the precursor blocks (Figure 2a). Attachment
of the ssDNA block was confirmed by UV-Vis spectro-
photometry of extensively dialyzed PPS-PEG-ssDNA,
characterized by the appearance of a peak at 260 nm for
both ssDNA-coupled samples (Figure 2c).
With the PEG-PPS copolymers and the polymer-
ssDNA conjugates complete, polymer-coated USPIO-
core micelles were formed using the thin film hydration
method [39]. In this process, a mixture of as-synthesized
USPIO cores and polymers in toluene is completely
dried by rotary evaporation, and then rehydrated to
form micelles. In concept, the hydrophobic PPS blocks
are expected to mingle with the oleic acid surfactant on
the USPIO surface, with the PEG blocks and ssDNA
extending into the surrounding aqueous medium, stabi-
lizing the micelle. The micellization process resulted in
a considerable amount of insoluble side products that
can be easily precipitated away by magnet, leaving a
colloidal phase that is then isolated into a fresh vial.
Free, unloaded PEG-PPS was colloidally unstable and
was easily removed by centrifugation, but the iron-
containing micelles appeared stable in water and did not
flocculate over several months. As little as 1.5:1 (w/w)
ratio of polymer to iron oxide is sufficient to render
PEG-PPS-USPIO micelles water-soluble. The micelles
exhibited hydrodynamic diameters of 41 nm as mea-
sured by DLS. They appear so colloidally stable that
they are extremely difficult to pellet without an ultra-
centrifuge, and are very slowly pelleted in proximity to a
1 T-field strength neodymium magnet. These observa-
tions have been suggested by other groups working with
colloidal USPIOs [40-42].
The morphology of the particles before and after
encapsulation in PEG-PPS was assessed by TEM. As-
made oleic acid-stabilized 12 ± 1 nm USPIO cores were
deposited and dried on the TEM grid from toluene and
generally appeared well-dispersed, but were also capable
of forming short-ranged packing structures that show-
cased their monodispersity (Figure 3a). These same
Figure 1 Synthesis of PEG-PPS-based polymer-biomolecule conjugates. The PPS block is formed by anionic ring-opening polymerization of
an episulfide monomer, and endcapped with methyl acrylate. Conversion of the terminal methyl ester group to a carboxylic acid is
accomplished under highly basic conditions to enable subsequent coupling of a PEG block and then a biofunctional ligand (e.g., peptides,
amine-functionalized ssDNA) in modular fashion, yielding PEG-PPS-based polymer-biomolecule conjugates.
Table 1 Molecular weight data for synthesized polymersa)
Polymers dn/dc at 40°C b) Mn Mw PDI Mn from NMR Average Degree of polymerization by NMR
mL/g Da Da unitless Da
PPS-COOH 0.246 1650 1950 1.18 874 10
H2N-PEG-COOH
c) – 4200 – – – 110
cPEG-PPS 0.183 7320 10200 1.39 5100 –
a) Molecular weight of polymers was determined by GPC-MALS. Polymers were injected into a TSKGel Mixed Bed HZM-N column (4.6 mm ID × 15 cm) and
chromatograms from the MALS detector and differential refractive index detector were used to analyze for polydispersity.
b) dn/dc values were measured in offline batch mode by direct injection of serial dilutions of polymer samples into the refractive index detector of the GPC. The
sample cell was maintained at 40°C. Data analysis was done on the Wyatt Astra software.
c) Values for Mn, Mw, and PDI were provided by manufacturer.
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observations applied for the cPEG-PPS encapsulated
USPIO micelles deposited and dried on the same copper
TEM grids out of water (Figure 3b). The addition of
PPS-PEG-ssDNA conjugates into the micellization pro-
cess immobilized ssDNA on the USPIOs and also pro-
duced micelles of similar morphology (Figure 3c-d).
These two populations of ssDNA-displaying USPIOs
can be then mixed to form longer-range clusters that
can be characterized by both TEM (Figure 3e) and DLS
(Figure 3f). As shown in Figure 3f, free ssDNA-display-
ing USPIO micelles exhibited hydrodynamic diameters
of ~70 nm (30 nm increase from the diameter exhibited
by PEG-PPS-USPIO micelles is easily attributable to the
length of the immobilized ssDNA sequences), while the
clusters display diameters of upwards of 1 μm. The
100-200 nm peak picked up by the DLS is attributable
Figure 2 Characterization of PEG-PPS copolymers. (A) GPC-MALS characterization of PPS-COOH (red), H2N-PEG-COOH (blue), and cPEG-PPS
(green). The cPEG-PPS sample displayed a population of polymers with peak elution time at ~9 min, corresponding to Mn = 7.32 kDa (see Table
1), in addition to excess unreacted H2N-PEG-COOH. (B) FT-IR spectra of the same three polymer samples confirm the formation of the
copolymer. The appearance of the 1700-1630 cm-1 peak and disappearance of the 1650-1590 cm-1 free amine bending peak in the copolymer
versus the unreacted PEG is consistent with the formation of an amide linkage between the N-terminus of the PEG block and the C-terminus of
the PPS block. (C) UV-Vis absorbance of cPEG-PPS (red) versus the post-dialyzed ssDNA-PEG-PPS conjugates (green, blue) confirms the
conjugation of ssDNA to the polymers, as referenced by the characteristic peak at 260 nm.
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to excess, unloaded non-iron-containing PEG-PPS
micelles that remain present in the samples, even fol-
lowing several centrifugation steps as described above.
The presence of the PEG-PPS coating was investigated
by thermogravimetric analysis (TGA) (Figure 3g). The
precursor OA-USPIOs displayed evaporation profiles
corresponding to oleic acid (250-350°C) and components
of the iron oxide core (350-450°C). It is unclear why
USPIO-associated oleic acid evaporated later than free
oleic acid, although it is interesting to note that our
results match those of other groups working on oleate-
stabilized USPIOs [43]. cPEG-PPS-USPIO micelles also
displayed two weight loss temperature ranges. The sharp
evaporation range at 390-410°C can be attributed to the
cPEG-PPS, while the long, gradual 200-390°C weight loss
range is very likely made up of a combination of oleic
acid evaporation, early cPEG-PPS desorption, and eva-
poration of iron oxide core components. This data sug-
gests that the oleic acid surfactant remains anchored on
the iron oxide cores during the micellization process
with PEG-PPS, rather than being displaced in a ligand-
exchange reaction. Taken together, this data suggests
PEG-PPS-based copolymers and conjugates were capable
of stably rendering water-soluble USPIOs displaying
immobilized ligands to the surrounding environment.
Clustering and de-clustering of complementary USPIOs
leads to modulation of R2 relaxivity coefficients
R2 coefficients were calculated based on measurements
of USPIO iron content through the phenanthroline
assay [44] and relaxation time measurements. For all
polymer-USPIO micelle samples, R2 values ranged
between 400-500 mM-1 s-1. These values were well
within expected ranges, and are similar in order of mag-
nitude to those recently measured by LaConte et al and
Lee et al [45,46]. Differences in the absolute R2 values
reported are easily accounted for, since LaConte et al
used USPIO cores of smaller diameters (~6 nm), while
Lee et al used USPIO cores that had been doped with
other metals such as manganese.
When C1-USPIOs and C2-USPIOs were mixed, the
hybridization of the surface-immobilized ssDNA
sequences resulted in crosslinking of the USPIOs into
larger clusters. This response is observed via an increase
in hydrodynamic diameters from ~70 nm to above 1 μm
(Figure 3f), and an increase in R2 coefficient to 690 ±
230 mM-1 s-1. These effects of USPIO clustering on R2
are consistent with previously published results by Ai
et al. [28]. Despite these previous demonstrations of this
phenomenon, the mechanisms behind this “MRS” effect
remain largely unstudied and are the subject of an
ongoing study in our group.
Since clustering of the complementary C1-USPIOs
and C2-USPIOs resulted in expected changes in R2, the
next goal was to determine whether reversal of the clus-
tering process would likewise correspondingly reverse
the observed increase in R2. Irreversible and reversible
‘declustering’ of the USPIO complexes was achieved
through enzymatic treatment and through thermocy-
cling experiments, respectively.
Figure 3 Properties of functionalized USPIOs. TEM of (A) as-made oleic acid-stabilized USPIO cores, (B) cPEG-PPS-USPIO micelles, (C) C1-
USPIOs, (D) C2-USPIOs, and (E) clusters formed by hybridization of C1-USPIOs and C2-USPIOs. All scale bars are in 100 nm. In the first four cases,
nanoparticles appear to be generally well-dispersed, but were also capable of forming short-ranged packing structures. (F) DLS size-volume
distributions of C1-USPIOs (blue), C2-USPIOs (red), and clusters formed by hybridization of C1- and C2-USPIOs (green) suggest that the individual
ssDNA-displaying USPIO micelles exhibit a hydrodynamic diameter of approximately 70 nm, while clusters formed by mixing the two
populations are generally greater than of 1 μm in diameter. (G) TGA weight loss curves of oleic acid (blue), cPEG-PPS (red), OA-USPIOs (yellow),
and cPEG-PPS-USPIOs (green) suggest that oleic acid is not displaced in the micellization process, and instead is encapsulated into the interior of
the micelles along with the iron oxide core.
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By design, the hybridization of USPIO-immobilized
C1- and C2- sequences reveals an EcoRV blunt end
cleavage site. Treatment of the clusters with EcoRV is
thus expected to redisperse the individual micelles,
resulting in irreversible return of the R2 values to the
baseline levels prior to the formation of the clusters.
The rate of de-clustering is expected to be controlled by
the relative concentrations of the enzyme and substrate.
The 4-hour enzyme treatment in this proof-of-concept
study allowed the de-clustering to go to completion.
These expectations are confirmed by relaxometry data
(Figure 4a), where a stable and significant difference in
R2 (p < 0.05) is measured following treatment with
EcoRV. The final R2 values remained stable for several
hours following enzymatic treatment, suggesting that
the declustering of the USPIOs was irreversible. In
contrast, clusters were alternatively treated with EcoRI
as a negative control, and the lack of a declustering
response is reflected in an insignificant change in the R2
coefficient of the system.
Next, reversible declustering of the USPIOs was
achieved through thermocycling, where R2 measure-
ments were made while the USPIO clusters were being
subjected to heating and cooling. In this process, heating
and cooling of the clusters melts and reanneals the
crosslinking DNA sequences, respectively. The resulting
changes in the clustering of USPIOs leads to expected
fluctuations in R2 (Figure 4b). The heated clusters are
expected to decluster, resulting in the return of R2
values to baseline levels prior to mixing C1-USPIOs and
C2-USPIOs. Allowing the system to cool is expected to
reanneal the DNA sequences and reform clusters,
returning R2 levels to the ranges expected for clusters.
Our observations matched these expectations. Heating
of the clusters resulted in approximately 50% decrease
in R2, while return of the system to room temperature
resulted in recovery of the original R2.
Conclusions
Novel PEG-PPS based polymer conjugates were synthe-
sized and characterized, then applied as a USPIO coat-
ing in the thin film hydration method to yield USPIO
micelles. The synthesis of ssDNA-tagged polymers and
the easy incorporation of these species into the micelle
formation process leads to the facile formation of
USPIO micelles that display biological ligands to the
surrounding media. The generation of complementary
populations of ssDNA-USPIOs results in a system that
is capable of detecting enzymatic cleavage events
through significant changes in R2 relaxation coefficient
of the system. These results motivate ongoing studies in
our group involving proteolytically-degradable USPIO




All materials and reagents were purchased from Sigma-
Aldrich (St. Louis, MO) and used as purchased unless
otherwise specified. Methyl acrylate was purchased from
Sigma-Aldrich (St. Louis, MO) and was purified by dis-
tillation prior to use. Heterobifunctional PEG reagents
were purchased from Laysan Bio (Arab, AL) and used as
purchased. The restriction enzymes EcoRI and EcoRV
were purchased from New England Biolabs (Ipswich,
MA). Custom ssDNA sequences designated C1 (5’-
amino-ACGTACGTGATATCTGCATGCA-3’) and C2
(5’-amino-TGCATGCAGATATCACGTACGT-3’) were
purchased from Sigma-Genosys. By design, C1 and C2
are complementary sequences that lack the ability to
Figure 4 Controlled release of USPIO micelles by
environmental triggers. (A) Self-assembly of EcoRV-sensitive
ssDNA-USPIO clusters, and subsequent enzymatic treatment results
in measurable changes in R2 relaxation coefficient relative to initial
values. Following EcoRV treatment, R2 values return to baseline, a
phenomenon that is in significant contrast to the effects of EcoRI
treatment of the same clusters (n = 6). * p < 0.05. (B) Thermocycling
of DNA-crosslinked USPIO clusters results in measurable changes in
R2 relaxation coefficient. Heating of the clusters melts the DNA and
results in declustering of the particles, corresponding to an
approximately 50% decrease in R2 coefficient. After allowing the
system to cool, the R2 coefficient increases to original levels,
suggesting the reclustering of the ssDNA-USPIOs (n = 3). * p < 0.05.
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self-hybridize into hairpins and other undesired
complexes.
Polymer samples were prepared for FT-IR spectro-
scopy by mixing with IR-grade KBr and pelleting on a
KBr press. FT-IR was performed on a Bruker Tensor 27
system. 1H NMR spectra were obtained at 400 MHz
using a 9.4 T Oxford magnet operated by a Bruker AV-
400 console. The main NMR probe for the instrument
is a 5 mm Z-gradient broadband inverse (BBI) probe
with automatic tuning and matching capability (ATM).
Gel permeation chromatography (GPC) was performed
on a Tosoh Biosciences TSKGel SuperHZ-M mixed bed
column (4 × 106 Da exclusion limit; DMF + 0.1 M LiBr
mobile phase) incubated at 60°C with a Shimadzu SPD-
10A UV detector and RID-10A refractive index detector
(Shimadzu Scientific Instruments, Columbia, MD), and
a Wyatt miniDAWN Treos multi-angle light scattering
detector (MALS; Wyatt Technology, Santa Barbara, CA).
Transmission electron microscopy (TEM) was con-
ducted on a Philips CM20 system. Carbon film-backed
copper grids (Electron Microscopy Sciences, Hatfield,
PA) were dipped into nanoparticle suspensions of inter-
est and blotted dry. This process was repeated three
times. Images were collected using a CCD camera with
AMT Image Capture Engine software (Advanced Micro-
scopy Techniques, Danvers, MA), and sizing of the par-
ticles was automated using a particle analyzer on ImageJ
software. For nanoparticle micelles deposited from
water, samples were dried in a vacuum desiccator for
2 h, and then counterstained with 3% uranyl acetate in
water (Electron Microscopy Sciences, Hatfield, PA) for
30 s, gently blotted dry, and further dried in the vacuum
desiccator for another 2 h prior to imaging.
For thermogravimetric analysis (TGA), samples were
weighed as approximately 5 mg and deposited into a
platinum pan for analysis with the Instrument Specia-
list’s TGA-1000 (Instrument Specialists, Inc., Twin
Lakes, WI). Samples were heated to approximately
200 K past their expected vaporization point and were
heated at a rate of 10 K per minute.
Synthesis and characterization of oleic acid-coated USPIO
cores
Synthesis of USPIO cores was done based on the proce-
dures described by Woo et al. [14]. Under argon gas
flow, oleic acid (3.8 mL, 12 mmol) was heated to 100°C
in 40 mL octyl ether in a three-neck flask. Fe(CO)5
(0.8 mL, 6 mmol) was then injected into the system,
and the mixture was then refluxed at 280°C for 4 h.
Next, the mixture was cooled to 80°C and aerated over-
night (> 14 h). The mixture was then refluxed for 2 h at
280°C and then cooled back to room temperature. Oleic
acid-stabilized USPIOs (OA-USPIOs) were collected
following three washes in ethanol and centrifugation,
and air dried overnight to form a dark brown-black
powder.
Synthesis of PPS-COOMe (1)
The PPS block was synthesized via anionic ring opening
polymerization of propylene sulfide from a deprotected
ethanethiol initiator (Figure 1). To form the initiator,
3 eq of the deprotectant 1,8-diazabicycloundec-7-ene
(DBU; 11.2 mL; 75 mmol) was mixed in 40 mL dry
DMF in a Schlenk tube, followed by the addition of 1 eq
of ethanethiol (1.85 mL; 25 mmol). The tube was evacu-
ated via a membrane pump and equilibrated with argon
6×, and then stirred at room temperature for 10 min.
Monomer was then added to the vessel by injection
of 10 eq propylene sulfide (19.6 mL; 250 mmol) into
the vial, and polymerization occurred for 90 min. In a
separate Schlenk tube, 10 eq distilled methyl acrylate
(22.5 mL; 250 mmol) was mixed with 5 eq triethylamine
(Et3N; 17.4 mL; 125 mmol). This vial was evacuated via
a membrane pump and equilibrated with argon gas 6×,
and then the contents were transferred under vacuum
into the PPS-containing vial. Upon mixing of the two
liquids, a color change is observed from orange to yel-
lowish. This mixture was then left to stir overnight at
room temperature. Concentrated product was obtained
by removal of DMF under high vacuum, and was redis-
solved in CH2Cl2 (100 mL). This solution was extracted
7 times in brine. The collected organic phase was then
dried over 5 g of sodium sulfate, and residual salts were
removed by gravity filtration through a #5 Whatman fil-
ter disc. The product was concentrated by incomplete
evaporation of the CH2Cl2 under vacuum, and then pre-
cipitated by addition to ice-cold hexanes for 30 min.
Centrifugation for 5 min at 800 × g pellets the PPS
block, and the hexane extraction step and centrifugation
was repeated a second time to yield PPS10-COOMe
(PPS-COOMe). Average degree of polymerization was
estimated by NMR. FT-IR (KBr) 1737 (s, ester C = O),
1490-1400 (t, C-H from PPS block and ethyl terminus
overlapped), 693 (s, CH2-S). δH (400 MHz; CDCl3): δ
1.2-1.3 (t, CH2 next to carboxylic terminus), 1.3-1.4 (d,
CH3 in PPS block & terminal CH3), 2.5-2.8 (broad s,
CH in PPS block), 2.8-3.1 (broad s, CH2 next to S), 3.72
(s, CH3 in ester).
Synthesis of PPS-COOH (2)
PPS10-COOH was synthesized from PPS10-COOMe (1)
by mixing the latter in 0.1 M NaOH in DMF at 65°C
for 5 h under open air in a fume hood (Figure 1). This
setup drives the reaction forward as the MeOH bypro-
duct evaporates directly into the environment. After the
reaction was cooled to room temperature, concentrated
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product was obtained by evaporation of DMF under
high vacuum, and was redissolved in CH2Cl2 (100 mL).
This solution was extracted 7 times in brine. The col-
lected organic phase was then dried over 5 g of sodium
sulfate, and residual salts were removed by gravity filtra-
tion through a #5 Whatman filter disc. The product was
concentrated by incomplete evaporation of the CH2Cl2
under vacuum, and then precipitated by addition to ice-
cold hexanes for 30 min. Centrifugation for 5 min at
800 × g pellets the PPS block, and the hexane extraction
step and centrifugation was repeated a second time to
yield PPS10-COOH (PPS-COOH), a viscous yellow
liquid, at more than 90% conversion, as confirmed by
NMR spectroscopy. The carboxylic acid terminus
remains unprotonated, as confirmed by the lack of the
corresponding proton peak on FT-IR and NMR. FT-IR
(KBr) 1737 (s, ester C = O; incomplete ester hydrolysis),
1713 (s, carboxylic C = O), 1490-1400 (t, C-H3 and C-
H2 overlapped), 693 (s, CH2-S). δH (400 MHz; CDCl3): δ
1.2-1.3 (t, CH2 next to carboxylic terminus), 1.3-1.4 (d,
CH3 in PPS block & terminal CH3), 2.5-2.8 (broad s,
CH in PPS block), 2.8-3.1 (broad s, CH2 next to S).
Synthesis of cPEG-PPS (carboxylated PEG-PPS; 3) and PPS-
PEG-ssDNA conjugates
PPS10-COOH (2), 2 g was dissolved into 3 mL of
CH2Cl2 and reacted with ~5 eq of N-hydroxysuccini-
mide (NHS; 1.44 g; 12.5 mmol), 1-Ethyl-3-(3-dimethyla-
minopropyl) carbodiimide hydrochloride (EDC; 2.40 g;
12.5 mmol), and Et3N (1.74 mL; 12.5 mmol) with gentle
vortexing for 4 h at room temperature. Following the
reaction, the crude product was concentrated by rotary
evaporation. Excess salts were precipitated and extracted
2× with brine and 3× with deionized water, and the pro-
duct was dried by rotary evaporation. 1 mL of the pro-
duct was redissolved in 5 mL of DMF, and then reacted
with ~0.1 eq of Mn 5 kDa H2N-PEG-COOH (625 mg;
~125 μmol) in the presence of 0.2 eq of Et3N (34 μL;
250 μmol) overnight. The crude product was concen-
trated by rotary evaporation, dissolved in 10 mL
CH2Cl2, and precipitated twice in diethyl ether under
ice for 1 h in order to remove unreacted PPS. Excess
organic solvents were removed by rotary evaporation,
and the crude product was dissolved in deionized water
and rinsed in 100 kDa MWCO centrifugal filters (Corn-
ing Life Sciences, Lowell, MA) with six fill volumes of
deionized water, to remove unbound PEG. Lyophiliza-
tion of the product overnight yielded cPEG-PPS (car-
boxylated PEG-PPS). δH (400 MHz; CDCl3): δ 1.2-1.3 (t,
CH2 next to carboxylic terminus), 1.3-1.4 (d, CH3 in
PPS block & terminal CH3), 1.4-1.8 (broad s, CH2 next
to COOH), 2.5-2.8 (broad s, CH in PPS block), 2.8-3.1
(broad s, CH2 next to S), 3.6-3.8 (s, CH2 in PEG block),
4.18 (s, NH in amide bond).
To construct the ssDNA-PEG-PPS conjugates, the 5’-
aminated custom ssDNA sequences C1 and C2 were
each separately reacted with cPEG-PPS in 5 mL sequen-
cing grade DMF in scintillation vials. 1.5 μmol of
each ssDNA sequence was transferred to each DMF-
containing vial in 0.5 mL NaCl buffer in water. Follow-
ing addition of equimolar amounts of cPEG-PPS, 5 eq
of EDC and Et3N were added to the reactions. The mix-
tures were briefly bubbled with argon gas, then capped
and vortexed for 2 h at room temperature. Following
rotary evaporation to remove excess DMF and Et3N, the
crude products were dissolved in DNAse-free water
(Sigma-Aldrich) and dialyzed separately in 30 kDa
MWCO centrifugal filters (Corning Life Sciences, Low-
ell, MA) with ten fill volumes of DNAse-free water. The
presence of DNA-polymer conjugates was confirmed by
the appearance of a 260 nm absorbance peak versus
unreacted cPEG-PPS, by UV-Vis spectrophotometry.
Encapsulation of USPIO core nanoparticles with polymers
USPIO-core, polymer-shell micelles/nanoparticles were
formed by the thin-film hydration method [39]. Briefly,
15 mg of purified PEG-PPS-based polymers were dis-
solved with 10 mg of OA-USPIOs in 1 mL toluene, vor-
texed to mix, sonicated for 5 s to break apart clumps,
and then dried by rotary evaporation for 20 min. The
dried polymer/USPIO mixture was then rehydrated in
5 mL of DNAse-free water and vortexed vigorously to
suspend all particulates. Large clumps and byproducts
are easily removed by magnetic pelleting, and the colloi-
dal phase is collected and further centrifuged at 2500 ×
g for 5 min to precipitate excess polymers. The superna-
tant is gently aspirated by pipet into fresh scintillation
vials and stored at 4°C.
Phenanthroline assay for iron content determination
To quantify the concentration of iron in all PEG-PPS-
USPIO formulations, the 1,10-phenanthroline assay was
used [44]. USPIOs in PBS (50 μL) were mineralized by
treatment in concentrated H2SO4 for 30 min at room
temperature, resulting in a loss of the dark brownish-
black color of the solution. This was followed by
treatment of the mixture with 10 μL 100 mg/mL hydro-
xylammonium chloride in water and 50 μL 1 mg/mL
1,10-phenanthroline in water. Development of an intense
orange color, corresponding to the presence of iron, is
observed upon addition of 550 μL 100 mg/mL sodium
acetate in water. Absorbance at 510 nm was measured on
a Varian Cary 50 UV-Vis-NIR spectrophotometer (Palo
Alto, CA). The concentration of free iron was calculated
based on a standard curve constructed using serial dilu-
tions of ferrous ammonium sulfate (Fisher Scientific,
Pittsburgh, PA) in water. Measurements of each sample
were done in triplicate.
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R2 relaxation measurements
A 0.5 T Maran tabletop NMR scanner with DRX-II con-
sole (Oxford Instruments, Oxfordshire, UK) was used
for transverse (T2) relaxation time measurements. 200
μL of PEG-PPS-USPIOs in PBS were loaded into 5-mm
thin-walled NMR tubes and introduced into the scanner.
Measurements were made using a Carr-Purcell-Mei-
boom-Gill (CPMG) sequence at room temperature, 32
echoes with 12 ms time between echoes, and an average
of 9 acquisitions. R2 relaxation coefficients were calcu-
lated based on the following formula [46], where [Fe] is
the iron content of the sample as determined through






For clustering/declustering experiments, 100 μL of
complementary ssDNA-USPIO populations were mixed
in the NMR tubes and allowed 10 min to cluster before
T2 was remeasured as described above. To study the
effects of restriction enzyme treatment, 500 U of EcoRI
or EcoRV were added to the tubes according to the man-
ufacturer’s instructions and the system was incubated at
37°C for 4 h before relaxation time was remeasured. To
study the effects of thermocycling, samples in NMR
tubes were heated to 85°C in a water bath for 15 min,
then measured in the relaxometer. The temperatures in
heated ssDNA-USPIO samples did not drop below 70°C
during the measurement process. Unless otherwise
noted, all presented data is the average of three indepen-
dent experiments. Statistical significance was established
using the paired Student’s t-test for all samples.
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